Teprotumumab shows efficacy and safety in both shorter and longer TED courses
- Posted on: Jun 8 2022
- Leave a response
An extension of the original OPTIC study was conducted to see if patients with a long duration of thyroid eye disease respond to teprotumumab treatment.
Source: AAO
Posted in: Uncategorized
